Crisantaspase
An enzyme derived from bacteria that breaks down asparagine, an amino acid that certain cancer cells depend on for survival. It is used to treat leukemia and lymphoma, starving tumor cells of a nutrient they cannot produce on their own.
Terapötik Alanlar
Pharmacokinetics (PK)
Pharmacodynamics (PD)
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
An enzyme derived from bacteria that breaks down asparagine, an amino acid that certain cancer cells depend on for survival. It is used to treat leukemia and lymphoma, starving tumor cells of a nutrient they cannot produce on their own.
Yes, Crisantaspase is an approved drug. It has reached clinical phase 4. It is classified as a Enzyme.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108931. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="crisantaspase"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/crisantaspase/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/crisantaspase/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/crisantaspase/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="crisantaspase"></drugfyi-drug>